First human test of experimental drug for meth addiction begins
NCT ID NCT06316973
Summary
This early-stage study tested the safety of an experimental drug called CS-1103 in healthy volunteers. Researchers gave 32 participants single, increasing doses through an IV to see how their bodies handled the drug and to check for side effects. The goal is to gather basic safety information as a first step toward developing a future treatment for methamphetamine addiction and overdose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBSTANCE USE DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Vince Clinical Research
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.